According to the WiseNews APP, trad chi med (00570) fell more than 5% again, and fell nearly 12% yesterday. As of press time, it fell 4.88% to HKD 3.51 with a turnover of HKD 167 million.

In February of this year, trad chi med announced that China National Pharmaceutical Group was planning to privatize trad chi med for HKD 4.6 per share. Compared with the closing price of HKD 3.43 before the suspension of trading, the privatization price this time was about 34.11% premium. According to the relevant shareholding ratio of China National Pharmaceutical Group, the total cost of this privatization was approximately HKD 15.45 billion. trad chi med believed that due to the limited trading volume in the secondary market, its function as a financing platform for listed companies was restricted.

It is worth noting that the company has been rumored to be privatized three times in three years, all of which have caused violent fluctuations in its stock price, but each time was denied. As early as January 2021, there were rumors that a consortium led by China National Pharmaceutical Group planned to privatize trad chi med for at least HKD 5.10 per share. In August of the same year, trad chi med announced that the privatization process would no longer be promoted.